Skip to main content
main-content

19.12.2015 | NEW STUDY | Ausgabe 2/2016

European Journal of Epidemiology 2/2016

Ophthalmic epidemiology in Europe: the “European Eye Epidemiology” (E3) consortium

Zeitschrift:
European Journal of Epidemiology > Ausgabe 2/2016
Autoren:
Cécile Delcourt, Jean-François Korobelnik, Gabriëlle H. S. Buitendijk, Paul J. Foster, Christopher J. Hammond, Stefano Piermarocchi, Tunde Peto, Nomdo Jansonius, Alireza Mirshahi, Ruth E. Hogg, Lionel Bretillon, Fotis Topouzis, Gabor Deak, Jakob Grauslund, Rebecca Broe, Eric H. Souied, Catherine Creuzot-Garcher, José Sahel, Vincent Daien, Terho Lehtimäki, Hans-Werner Hense, Elena Prokofyeva, Konrad Oexle, Jugnoo S. Rahi, Phillippa M. Cumberland, Steffen Schmitz-Valckenberg, Sascha Fauser, Geir Bertelsen, Carel Hoyng, Arthur Bergen, Rufino Silva, Sebastian Wolf, Andrew Lotery, Usha Chakravarthy, Astrid Fletcher, Caroline C. W. Klaver
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s10654-015-0098-2) contains supplementary material, which is available to authorized users.
On behalf of the European Eye Epidemiology (E3) consortium.
Please see “Appendix” section for European Eye Epidemiology (E3) consortium members.

Abstract

The European Eye Epidemiology (E3) consortium is a recently formed consortium of 29 groups from 12 European countries. It already comprises 21 population-based studies and 20 other studies (case–control, cases only, randomized trials), providing ophthalmological data on approximately 170,000 European participants. The aim of the consortium is to promote and sustain collaboration and sharing of data and knowledge in the field of ophthalmic epidemiology in Europe, with particular focus on the harmonization of methods for future research, estimation and projection of frequency and impact of visual outcomes in European populations (including temporal trends and European subregions), identification of risk factors and pathways for eye diseases (lifestyle, vascular and metabolic factors, genetics, epigenetics and biomarkers) and development and validation of prediction models for eye diseases. Coordinating these existing data will allow a detailed study of the risk factors and consequences of eye diseases and visual impairment, including study of international geographical variation which is not possible in individual studies. It is expected that collaborative work on these existing data will provide additional knowledge, despite the fact that the risk factors and the methods for collecting them differ somewhat among the participating studies. Most studies also include biobanks of various biological samples, which will enable identification of biomarkers to detect and predict occurrence and progression of eye diseases. This article outlines the rationale of the consortium, its design and presents a summary of the methodology.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Weitere Produktempfehlungen anzeigen
Zusatzmaterial
Nur für berechtigte Nutzer zugänglich
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 2/2016

European Journal of Epidemiology 2/2016 Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.